News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 255 results

BGI wins partial lifting of Illumina injunction

US13-08-2020Rory O'Neill

Beijing-based BGI Genomics can continue to develop its DNA sequencing technology pending an appeal in a patent dispute with Illumina, a US federal court has ruled.

KIPA hires former Decode Genetics director

Iceland, Sweden06-08-2020Sarah Morgan

IP boutique KIPA has strengthened its team with the addition of Iceland-based patent attorney Thorlakur Jonsson. 

Fed Circuit orders new Bio-Rad trial, but upholds $24m award

US04-08-2020Muireann Bolger

The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent.

Personal Genomics takes PacBio dispute to Chinese court

China22-05-2020Rory O'Neill

Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

Natera and Illumina settle litigation, agree mutual licence

14-05-2020

Natera has agreed to license Illumina IP covering non-invasive prenatal testing (NIPT), in a deal that sees the pair settle all outstanding patent litigation over the technology.

Merck expands CRISPR patent portfolio

US12-05-2020Rory O'Neill

Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

Merck KGaA secures second US CRISPR patent

US09-04-2020Sarah Morgan

Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23. 

EIP boosts life sciences practice with Mathys & Squire partner

UK02-04-2020

IP law firm EIP has enhanced its life science capabilities with the addition of Monika Rai as a partner. 

Webinar: Plenty to fight for in CRISPR IP battle

US26-03-2020

Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

PacBio pledges to fight invalidation of patents after bitter dispute

US19-03-2020Rory O'Neill

California-based Pacific Biosciences has accused a UK rival of exploiting the coronavirus pandemic in a patent infringement trial.

Showing 1 to 10 of 255 results

LSIPR